Lifestyle
- Increase physical activity
- Quit smoking
- Maintain a healthy weight
High-Density Lipoprotein · HDL-C · HDL
HDL-C measures the concentration of high-density lipoprotein cholesterol in the blood.
Reference ranges may vary slightly by laboratory and population. Fasting is recommended for accurate measurement.
High-Density Lipoprotein Cholesterol (HDL-C) is a type of cholesterol carried in the blood by high-density lipoproteins. It is often referred to as 'good cholesterol' due to its role in transporting cholesterol from the arteries to the liver for excretion or re-utilization. HDL-C is a key component of lipid profiles used to assess cardiovascular health. Clinically, HDL-C levels are inversely associated with the risk of atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, peripheral vascular disease, and cerebrovascular disease. Low levels of HDL-C are linked to increased risk of metabolic syndrome and cardiovascular diseases, while very high levels may also pose risks. In the context of athletic performance and biohacking, maintaining optimal HDL-C levels is considered beneficial for cardiovascular health and longevity. However, researchers have noted that both extremely low and high HDL-C levels can be associated with genetic disorders or other health conditions. Confounders such as diet, exercise, and medication can influence HDL-C levels, and fasting is typically recommended before testing to ensure accurate results.
Klinische Bedeutung
Elevated HDL-C is generally considered protective against cardiovascular disease, while low HDL-C levels are associated with increased risk of ASCVD. However, extremely high HDL-C levels may indicate genetic disorders and could also pose health risks.
Progressively rising HDL-C levels generally suggest improved cardiovascular health, but extremely high levels should be evaluated for potential genetic causes.
Progressively falling HDL-C levels may indicate increased cardiovascular risk and warrant lifestyle or medical intervention.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting any supplementation, especially if taking other medications.
Testing Frequency
Annually for adults at risk of cardiovascular disease.
Current research suggests that the molecular mechanisms linking HDL-C to tumor incidence and prognosis remain understudied, with conflicting views on its role in cancer. Researchers have not yet established optimal HDL-C reference ranges or targets for various populations, particularly in the context of metabolic syndrome and cardiovascular disease. Additionally, clinical questions regarding the impact of genetic variations on HDL-C levels and their implications for personalized treatment strategies remain unanswered.
654
Total Citations
7
Human/RCT
3.5
Avg. Influence
2021
Latest
This study examined the relationship between the triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio and the risk of metabolic syndrome and cardiovascular disease (CVD). Researchers found that increased TG levels and decreased HDL-C levels are associated with higher risks of these conditions, suggesting that the TG/HDL-C ratio could serve as a valuable predictor for CVD.
Researchers observed that low levels of high-density lipoprotein cholesterol (HDL-C) are significant risk factors for cardiovascular disease (CVD). The study emphasizes the importance of genetic analysis in diagnosing HDL deficiency and its associated health risks.
This study explored the relationship between high-density lipoprotein cholesterol (HDL-C) and bone mineral density (BMD) in U.S. adults. Researchers found a positive association, particularly in women, suggesting HDL-C may serve as a biomarker for early osteoporosis detection.
This study investigated hypertriglyceridemia in obese children and adolescents, focusing on the TG/HDL-C ratio as a marker of cardiometabolic risk. Researchers found that elevated TG levels are common in this population and recommended lifestyle modifications to manage triglyceride levels.
This review analyzed the role of high-density lipoprotein cholesterol (HDL-C) in colorectal cancer (CRC). Researchers found that HDL-C levels decrease in CRC patients, and emphasized the need for further studies on HDL functionality and its potential as a biomarker in CRC.
This review focused on the relationship between high-density lipoprotein (HDL) and cancer, particularly in endocrine carcinomas. Researchers observed that HDL-C levels may inversely correlate with cancer risk and suggested potential therapeutic applications of synthetic HDL in cancer treatment.
This literature review explored the role of high-density lipoprotein cholesterol (HDL-C) in age-related ocular diseases. Researchers found limited understanding of HDL-C's specific impact on conditions like age-related macular degeneration and diabetic retinopathy.
Researchers found a negative association between high-density lipoprotein cholesterol (HDL-C) levels and tumor incidence, suggesting that measuring HDL-C could help assess cancer prognosis. However, the molecular mechanisms linking HDL-C to tumor development remain unclear.
Researchers reviewed novel recombinant high-density lipoprotein (HDL) formulations aimed at mitigating cardiovascular disease (CVD) risk. The study highlights the need for further clinical trials to evaluate the efficacy of these HDL-modifying therapies.
This study explored the non-linear association between the platelet-to-high-density lipoprotein cholesterol (PHR) ratio and bone mineral density (BMD). Researchers found a complex, inverted U-shaped relationship, indicating that optimal PHR levels are important for maintaining bone health. The findings suggest that PHR may reflect inflammatory states affecting bone resorption.
Research publications about HDL-Cholesterin over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer